One-year Outcomes with Angiographic Follow-Up of Paclitaxel-Eluting Balloon for the Treatment of In-Stent Restenosis: Insights from Spanish Multicenter Registry

Abstract

In a real-world population, treatment of ISR (including 48% DES-ISR) with this DEB provides good mid-term results with 12% TLR at 1 year, especially in ISR pattern IC (9% MACE).